BLACW

Bellevue Life Sciences A... (BLACW)

Bellevue Life Sciences Acquisition Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BLACW

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/11/15	07 : 06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/11/13	06 : 52	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/10/28	22 : 02	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/10/28	22 : 00	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/10/28	21 : 33	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/10/28	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/10/23	05 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/10/19	06 : 29	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/10/16	05 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/10/11	05 : 35	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/10/11	05 : 33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/10/11	05 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/09/25	05 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/09/17	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/06/14	05 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/05/31	05 : 30	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/05/16	05 : 31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/05/15	05 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/05/13	22 : 18	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/05/13	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/05/11	04 : 14	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation
2024/05/11	04 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLACW	Bellevue Life Sciences Acquisition Corporation